Everolimus in advanced/metastatic renal cell carcinoma in adults after sunitinib progression

被引：0
|
作者：
Martin-Vila, A. [1 ]
Alvarez-Payero, M. [1 ]
Martinez-Lopez de Castro, N. [1 ]
Suarez-Santamaria, M. [1 ]
Castro-Dominguez, J. M. [1 ]
Ascunce-Saldana, M. D. P. [1 ]
机构：
[1] Hosp Meixoeiro, Complexo Hosp Univ Vigo, Vigo, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：907 / 907
页数：1
相关论文
共 50 条
  • [1] Sunitinib in advanced/metastatic renal cell carcinoma in adults
    Martin Vila, A.
    Alvarez Seoane, J.
    Perez Parente, D.
    Alvarez Payero, M.
    Ucha Samartin, M.
    Martinez Lopez de Castro, N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 239 - 239
  • [2] The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma
    Iacovelli, Roberto
    Rocca, Maria Cossu
    Galli, Luca
    Sabbatini, Roberto
    De Giorgi, Ugo
    Santini, Daniele
    Facchini, Gaetano
    Mosca, Alessandra
    Atzori, Francesco
    Zucali, Paolo
    Fornarini, Giuseppe
    Massari, Francesco
    Buti, Sebastiano
    Ricotta, Riccardo
    Masini, Cristina
    Toscani, Ilaria
    Biasco, Elisa
    Guida, Annalisa
    Lolli, Cristian
    De Lisi, Delia
    Rossetti, Sabrina
    Terrone, Carlo
    Scartozzi, Mario
    Miggiano, Chiara
    Pastorino, Alessandro
    Bersanelli, Melissa
    Carlo-Stella, Giulia
    Pinto, Carmine
    Nobili, Elisabetta
    Nole, Franco
    Tortora, Giampaolo
    Porta, Camillo
    ANTI-CANCER DRUGS, 2018, 29 (07) : 705 - 709
  • [3] Sunitinib in advanced metastatic renal cell carcinoma
    Gonzalez, Diana
    Casado, Gema
    Sierra, Ana
    Tacoronte, Angeles M.
    Herrero, Alicia
    Zamora, Pilar
    Jimenez, Esperanza
    PHARMACY WORLD & SCIENCE, 2008, 30 (05): : 674 - 674
  • [4] Clinical outcomes in patients with metastatic renal cell carcinoma receiving everolimus or temsirolimus after sunitinib
    Iacovelli, Roberto
    Carteni, Giacomo
    Milella, Michele
    Berardi, Rossana
    Di Lorenzo, Giuseppe
    Verzoni, Elena
    Rizzo, Mimma
    Santoni, Matteo
    Procopio, Giuseppe
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (3-4): : E121 - E125
  • [5] Sunitinib dose escalation after disease progression in metastatic renal cell carcinoma.
    Raphael, Jacques
    Thawer, Alia
    Bjarnason, Georg A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [6] Sunitinib dose-escalation after disease progression in metastatic renal cell carcinoma
    Raphael, Jacques
    Thawer, Alia
    Bjarnason, Georg A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (01) : 12.e1 - 12.e6
  • [7] Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
    Molina, Ana M.
    Ginsberg, Michelle S.
    Motzer, Robert J.
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1527 - 1529
  • [8] Phase 1 Trial of Everolimus Plus Sunitinib in Patients With Metastatic Renal Cell Carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Voss, Martin H.
    Ginsberg, Michelle S.
    Baum, Michael S.
    Brocks, Dion R.
    Fischer, Patricia M.
    Trinos, Michael J.
    Patil, Sujata
    Motzer, Robert J.
    CANCER, 2012, 118 (07) : 1868 - 1876
  • [9] Long-term response with everolimus for metastatic renal cell carcinoma refractory to sunitinib
    Ana M. Molina
    Michelle S. Ginsberg
    Robert J. Motzer
    Medical Oncology, 2011, 28 : 1527 - 1529
  • [10] Sunitinib for metastatic renal cell carcinoma
    Mukherji, Deborah
    Larkin, James
    Pickering, Lisa
    FUTURE ONCOLOGY, 2010, 6 (09) : 1377 - 1385
12345